Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novelos reports imaging results with [124I]-CLR-1404 in brain cancer

June 20, 2012

Phase III crizotinib study meets endpoint

June 20, 2012

ETS-2101 trial in brain cancer begins enrollment

June 20, 2012

Novartis reports novel CDK9 inhibitors

June 20, 2012

Infinity Pharmaceuticals halts saridegib trials

June 19, 2012

Genta reaches agreement on phase III tesetaxel trial

June 19, 2012

New CDK9 inhibitors presented by Novartis

June 19, 2012

Collaborating companies design novel anticancer agents

June 19, 2012

Tosedostat studied for elderly patients with AML or high-risk MDS

June 18, 2012

Debiopharm and Ascepion enter license agreement for multikinase inhibitor

June 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...